Kevin Keegan

Company: Illumina

Job title: GM Oncology

Seminars:

Realising the Power of Sequencing Across the Patient Pathway in Therapy Selection & Monitoring 8:55 am

The strategic partner of choice to serve all of pharma’s genomic need A glance into the future, exploring Illumina’s forthcoming Innovations:   Towards development of distributable assays for therapy monitoring and minimum residual disease (MRD) detection Illumina’s globally distributed CGP CDx strategy delivering future-proof solutions to your oncology pipelinesRead more

day: Day One